HOME >> MEDICINE >> NEWS
Panel presents Agricultural Biosecurity & Sustainability Strategies at 2007 AAAS Meeting

ons to enhance the ability to rapidly identify, contain, respond, and recover from intentional contamination, both real and threatened.

  • Jacqueline Fletcher, Oklahoma State University, The American Phytopathological Society
    Emerging and Threatening Plant Pathogens: Assuring Biopreparedness

    A safe agricultural system is critical to national security, but U.S. crops, a cornerstone of our nation's economy, are vulnerable to attack. Plant pathogens that are devastating to crops elsewhere, but are not yet present in the U.S., could be easily obtained by terrorists. Potential costs of a terrorist attack include reductions in crop yield and quality, increased production costs and food prices, financial instability of rural communities, and loss of public confidence in the food supply. Fletcher will discuss strategies currently in place and what is still needed to keep U.S. crops safe.

  • David Franz, National Agricultural Biosecurity Center, Midwest Research Institute
    Animal Biosecurity Is Vital to Global Food Industry, Health, and Trade

    The livestock industry contributes hundreds of billions of dollars to the U.S. economy annually. For years, we have protected our herds and flocks very effectively from both natural and accidentally-introduced disease. Yet, our own efficiency in this shrinking world and in this age of terrorism has made us ever more vulnerable. Franz will discuss vulnerabilities, threats and some technical and non-technical considerations.

  • David A. Hennessy, Iowa State University
    Getting the Incentives Right on the Farm

    Agricultural biosecurity threats can be intentional or inadvertent. This presentation will consider biosecurity issues according to the nature of the threat, the agricultural crop, and the stage of the value-added chain. It will discuss approaches to strengthening incentives to take efficient actions. Particular attention will be paid to
    '"/>



  • Contact: Amy Steigman
    asteigman@scisoc.org
    651-994-3802
    American Phytopathological Society
    18-Feb-2007


    Page: 1 2 3

    Related medicine news :

    1. Panel offers guidelines on skin reactions to new class of cancer drugs
    2. Panel offers expert analysis on causes, prevention of stent thrombosis
    3. Panel updates guidelines for treatment of adult HIV infection
    4. Panel finds insufficient evidence to recommend for or against maternal-request Caesarean delivery
    5. Panel calls for a new look at treatments commonly used for chronic insomnia
    6. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
    7. The quest for an effective HIV vaccine presents new possibilities, challenges
    8. Alpharma presents positive pharmacokinetic study results
    9. Rutgers presents Susman award to College of Nursing faculty member Marlene Rankin
    10. XDx presents success with AlloMap molecular expression testing to international transplant community
    11. Childrens Hospital Boston presents at the American College of Cardiology Scientific Sessions

    Post Your Comments:
    (Date:7/21/2014)... PowerObjects, a professional services firm ... add-ons for Microsoft Dynamics CRM, has joined the ... group of the most strategic Microsoft Dynamics partners ... rank them in the highest echelon of the ... the Microsoft Dynamics Inner Circle have performed to ...
    (Date:7/21/2014)... have a clot in their legs and are ... medication or undergo a minimally-invasive catheter-based clot removal ... difference in death rates between the two treatments, ... catheter procedure, according to a study by Temple ... a review of more than 90,000 cases nationwide., ...
    (Date:7/21/2014)... The "viral reservoir" in which HIV can lie dormant ... earlier than previously thought, new animal research indicates. ... eradicate the AIDS-causing virus, said Harvard researchers working with ... presence of the viral reservoir remains the most significant ... HIV, known as HIV-1. "We found that the ...
    (Date:7/21/2014)... (PRWEB) July 21, 2014 Western ... “Great College to Work For” by the Chronicle ... and also made the Honor Roll for the ... categories: Collaborative Governance, Compensation and Benefits, Confidence in ... Respect & Appreciation. , “Western University of Health ...
    (Date:7/21/2014)... A new study suggests that potential help in lowering ... refrigerator. The study found that regular intake of ... supplements, may help ease the condition. Researchers looked ... probiotics and blood pressure. The studies involved a total ... pressure. People who consumed probiotics had an average ...
    Breaking Medicine News(10 mins):Health News:PowerObjects Joins the 2014 Microsoft Dynamics Inner Circle 2Health News:Temple study compares deep vein thrombosis therapies 2Health News:Temple study compares deep vein thrombosis therapies 3Health News:Temple study compares deep vein thrombosis therapies 4Health News:Animal Experiments Shed Light on HIV's Ability to Hide 2Health News:Western University of Health Sciences Elevated to “Great College to Work For” Honor Roll 2Health News:Could Probiotics Help Tame High Blood Pressure? 2
    (Date:7/21/2014)... , July 21, 2014 Integrity Applications, ... of the GlucoTrack ® model DF-F noninvasive ... has entered, through its wholly-owned subsidiary, Integrity Applications ... the manufacturing arm of Acer Inc.  Pursuant to ... service (on a non-exclusive basis) the GlucoTrack Model ...
    (Date:7/21/2014)... Calif. , July 21, 2014   ... a biopharmaceutical company leading the discovery and development ... the U.S. Food & Drug Administration (FDA) has ... stranded, chemically modified oligonucleotide that binds to and ... therapeutic for the treatment of Alport syndrome, a ...
    (Date:7/21/2014)... -- An International Trade Commission (ITC) ruling issued Friday held ... Taiwanese device manufacturer APEX continues to infringe ResMed patents ... is the innovation leader and pioneer in designing and ... "Our research and development teams are constantly ... comfort, performance and efficacy," said David Pendarvis , ...
    Breaking Medicine Technology:Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 2Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp. 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 2Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 3Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 4Regulus Receives Orphan Drug Designation for RG-012, a microRNA Therapeutic for the Treatment of Alport Syndrome 5ITC Rules Redesigned APEX Humidifier Still Infringes ResMed Patents 2
    Cached News: